Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00273507
Status:
TERMINATED
Last Update Posted:
2009-09-18
First Post:
2006-01-05
Brief Title:
Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer NSCLC Stages IB IIA IIB and IIIAT3
Sponsor:
Rigshospitalet Denmark
Organization:
Rigshospitalet Denmark
Study Overview
Official Title:
Neoadjuvant Chemotherapy in Resectable NSCLC Stages IB IIA IIB and IIIAT3 But Not IIIAN2
Status:
TERMINATED
Status Verified Date:
2009-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Randomised trial of chemotherapy or not before surgery in early resectable stages of NSCLC IB IIA IIB and IIIAN2
Detailed Description:
Randomisation between 3 courses of neoadjuvant Carboplatin plus Paclitaxel or no chemotherapy before surgery
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None